---
title: RHD & IE Quick Guide (INICET)
markmap:
  colorFreezeLevel: 6
---

## Rheumatic Heart Disease (RHD)

- Etiology: Strep pyogenes (GAS) Pharyngitis
- Pathogenesis: Autoimmune, Molecular Mimicry
  - **Aschoff Bodies** (myocardial granuloma)
  - **Anitschkow Cells** (Caterpillar cells - activated macrophages)
- Modified Jones Criteria (Diagnosis)
  - **Major:** (2 Major OR 1 Major + 2 Minor + Evidence of Strep)
    - **Carditis** (most serious)
    - **Polyarthritis** (most common, migratory large joints)
    - **Sydenham Chorea** (St. Vitus' Dance)
    - **Erythema Marginatum** (non-itchy, annular rash)
    - **Subcutaneous Nodules** (firm, painless over bony prominences)
  - **Minor:**
    - Fever
    - Arthralgia
    - Elevated ESR/CRP
    - Prolonged PR interval on ECG
    - Previous RHD history
  - **Plus:** Evidence of recent Strep infection (ASO titer, Anti-DNase B, positive throat culture)
- Cardiac Involvement (Order: Mitral > Aortic > Tricuspid > Pulmonic)
  - Acute: Mitral Regurgitation (most common initial valve lesion)
  - Chronic: **Mitral Stenosis** (classical "fish-mouth"), Aortic Regurgitation
- Complications
  - Heart Failure
  - Arrhythmias (AFib in MS)
  - Thromboembolism (in MS)
  - **Infective Endocarditis** (can superimpose)
- Prevention
  - Primary: Treat Strep throat effectively (Penicillin)
  - Secondary: **Benzathine Penicillin G** IM (every 3-4 weeks) - duration varies based on carditis severity
- Management:
  - Anti-inflammatory (Aspirin, Steroids for moderate/severe Carditis)
  - Symptomatic (Diuretics, Digoxin for HF)
  - Valve Surgery (for severe regurgitation or stenosis)

## Infective Endocarditis (IE)

- Risk Factors
  - **Prosthetic Valves** (Highest Risk)
  - Previous IE history
  - Valvular Heart Disease (RHD, Bicuspid Aortic Valve, MVP with significant MR)
  - **IV Drug Use**
  - Structural Heart Disease (VSD, PDA, complex cyanotic defects)
  - Indwelling Catheters, Cardiac Devices (PPM, AICD)
- Microbiology (Key Organisms)
  - **Native Valves:** **Viridans Streptococci** (most common overall), Staph Aureus
  - **Acute IE:** **Staph Aureus** (most virulent, often on previously normal valves)
  - **IV Drug Use IE:** **Staph Aureus** (commonly Tricuspid valve)
  - **Prosthetic Valve Endocarditis (PVE):**
    - Early (<1 year post-op): **Coagulase-negative Staph** (**S. epidermidis**), Staph Aureus
    - Late (>1 year post-op): Viridans Strep, Staph Aureus, Enterococci
  - **HACEK organisms** (fastidious Gram-negative: Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella)
  - **Culture-Negative IE:** (often due to prior antibiotics) Coxiella burnetii (Q fever), Bartonella spp.
- Modified Duke Criteria (Diagnosis)
  - **Major:** (2 Major OR 1 Major + 3 Minor OR 5 Minor)
    - **Positive Blood Culture** (typical organisms from 2 separate cultures; persistent bacteremia)
    - **Evidence of Endocardial Involvement** (Echocardiogram: **Vegetation**, Abscess, new partial dehiscence of PVE, new valvular regurgitation)
  - **Minor:**
    - Predisposing heart condition or IVDU
    - Fever (>38Â°C)
    - **Vascular Phenomena:** Arterial emboli, Septic pulmonary infarcts, **Mycotic Aneurysm**, Intracranial hemorrhage, **Janeway lesions** (painless, palms/soles)
    - **Immunologic Phenomena:** Glomerulonephritis, **Osler nodes** (painful, fingers/toes), **Roth spots** (retina, pale center), Rheumatoid factor
    - Microbiological evidence (positive culture not meeting major criteria)
- Clinical Features
  - **Fever** (most common symptom)
  - New or changing heart murmur
  - Peripheral Stigmata (often late/less common now): **Janeway lesions**, **Osler nodes**, **Splinter hemorrhages**, **Roth spots**
  - Systemic/Pulmonary Emboli symptoms
- Diagnosis
  - **Blood Cultures:** Crucial (multiple sets, different sites)
  - **Echocardiography:** **TEE** (**Transesophageal Echo**) generally superior to TTE for detecting vegetations, abscesses
- Complications (Major Causes of Morbidity/Mortality)
  - **Heart Failure** (most common cause of death - due to valve damage)
  - **Embolization** (systemic to brain, spleen, kidneys, limbs; pulmonary in right-sided IE)
  - Local Spread: **Abscess formation** (valve ring, myocardium), Pseudoaneurysm, Fistula
  - **Mycotic Aneurysms** (infected arterial aneurysms, often cerebral)
  - Renal Failure (Glomerulonephritis, septic emboli)
- Management
  - **Antibiotics:** Prolonged IV course (4-6 weeks minimum), empiric initially, then guided by culture & sensitivity. High doses, often combinations.
  - **Surgery:** (Valve repair or replacement) - **Indications for Surgery:**
    - **Heart Failure** (severe valve dysfunction)
    - **Uncontrolled Infection** (persistent bacteremia/fever despite antibiotics, local complications like abscess/fistula)
    - **Prevention of Embolization** (**Large Vegetations** >10-15mm, particularly on mitral/aortic valve, after embolization despite antibiotics)
    - **Prosthetic Valve Endocarditis** (often requires surgery)
    - Fungal Endocarditis
- Prophylaxis (Select High-Risk Patients & Procedures)
  - **High-Risk Conditions:** Prosthetic valves, Hx of IE, Certain congenital heart disease, Cardiac transplant with valvulopathy
  - **Procedures:** **Dental** procedures involving gingival tissue/periapical region, Respiratory/Skin procedures on infected tissue.

## INICET Buzzwords

  - RHD: 
    - **Aschoff**
    - **Anitschkow**
    - **Jones Criteria**
    - **Mitral Stenosis (MS)**
    - **Sydenham Chorea**
    - **Erythema Marginatum**
    - **Benzathine Penicillin Secondary Prophylaxis**
  - IE: 
    - **Duke Criteria**
    - **Vegetation** (on Echo)
    - **TEE** (Transesophageal Echo)
    - **Staph Aureus IVDU**
    - **Viridans Strep Native**
    - **Prosthetic Valve Endocarditis (PVE)**
    - **S. epidermidis** (Early PVE)
    - **HACEK**, **Janeway lesions** (painless emboli)
    - **Osler nodes** (painful immunologic)
    - **Roth spots**
    - **Splinter Hemorrhages**
    - **Mycotic Aneurysm**
    - **Heart Failure (most common death cause)**
    - **Surgical Indications IE**
    - **Large Vegetation**
